SUBSCRIBE
SUBSCRIBE

Alliances

Novartis to Hold On to Its 33% Stake in Roche—For Now
Business
Novartis AG Scoops Up U.S. Sickle Cell Drugmaker Selexys in $665 Million Deal
November 21, 2016
 · 
2 min read
Ex-Akebia Director Re-arrested After Insider Trading Prosecutors Call Him Unhinged
Business
Embattled GlobeImmune Loses Gilead Deal, Cancels HQ Lease, and CEO Resigns
November 17, 2016
 · 
2 min read
Business
What’s The Sweet Spot For Digital Health Collaborations With Pharma Clinical Studies?
November 10, 2016
 · 
1 min read
3 Biotechs Breathing Down Bristol-Myers Squibb's Neck
Business
Bristol-Myers Squibb Slams Down $100 Million to Make a Play Into NASH
November 10, 2016
 · 
3 min read
Tiny KalVista Explodes on $760 Million Deal With Drug Giant Merck & Co.
Business
Celldex Takes Out Kolltan Pharma in $235 Million Deal
November 2, 2016
 · 
2 min read
Bay Area Startup Arcus Biosciences Lands $307 Million+ Deal With Taiho Pharma
Business
Little-Known Ganymed Grabs a $1.4 Billion Buyout Deal From Astellas
October 28, 2016
 · 
2 min read
Business
Biogen Could Add $1 Billion In 2017 On Muscular Dystrophy Drug
October 25, 2016
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Shire Pays CTI BioPharma $10.3 Million to Terminate Cancer Deal it Picked Up From Baxalta
October 24, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Business
Alkermes’ Success Puts the Spotlight on Cerecor, Eli Lilly’s 2015 Deal
October 21, 2016
 · 
2 min read
AbbVie Leaps Into the Land of Oncolytics With New Turnstone Biologics Tie-Up
Business
AbbVie Abandons Arthritis Pact With Ablynx
October 20, 2016
 · 
3 min read
Load More
PRESS RELEASES
Press Releases
Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma
August 28, 2025
 · 
3 min read
Press Releases
Pendopharm® signs an exclusive distribution agreement with Neuraxpharm for PrBuccolam® in Canada and announces its approval by Health Canada
August 4, 2025
 · 
4 min read
Press Releases
Regenerex Pharma, Inc. Enters Into Licensing Agreement with Holista Colltech Ltd.
July 31, 2025
 · 
3 min read
Press Releases
Accelerating Impact: AstraZeneca and Revna Biosciences Expand Access to Lung Cancer Treatment in Ghana
July 30, 2025
 · 
4 min read
Press Releases
JCR Pharmaceuticals Enters License Agreement with Alexion for Proprietary JUST-AAV Capsids to be Used in the Development of Genomic Medicines
July 8, 2025
 · 
5 min read
Press Releases
Sumitomo Pharma America and Former Professional Quarterback Rodney Peete Say it’s Time to Go™ and Put Yourself First with Overactive Bladder Treatment Option GEMTESA®
June 30, 2025
 · 
8 min read
Press Releases
Mabwell Announces Novel Drug Technology License Agreement with Qilu Pharmaceutical for Albipagrastim alfa for Injection
June 27, 2025
 · 
5 min read
Press Releases
Miraomics, Pythia Biosciences and LatchBio Release a 30 Million Cell Atlas and an Agentric AI Framework for Molecular Data Curation
June 27, 2025
 · 
2 min read
Press Releases
Cyberlux Corporation Signs Strategic MoU with George Mason University to Accelerate Defense Innovation and Technology Commercialization
June 27, 2025
 · 
3 min read
Press Releases
Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
June 26, 2025
 · 
5 min read
Press Releases
Positive Preliminary Cohort B Results from the AGITG-led ASCEND Trial to be Presented at ESMO GI Evaluating Lisata’s Certepetide in Combination with Standard-of-Care Chemotherapy in Metastatic Pancreatic Cancer
June 26, 2025
 · 
10 min read
Press Releases
CMUH and Shine-On Biomedical Lead Taiwan’s Push into Global Exosome-Based Precision Medicine
June 26, 2025
 · 
3 min read
Press Releases
KalVista Pharmaceuticals Enters into Licensing Agreement with Pendopharm to Commercialize Sebetralstat for HAE in Canada
June 26, 2025
 · 
4 min read
Press Releases
Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset
June 25, 2025
 · 
7 min read
Press Releases
Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.
June 25, 2025
 · 
5 min read
Press Releases
Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences
June 25, 2025
 · 
5 min read
Press Releases
Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
June 25, 2025
 · 
5 min read
Press Releases
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis
June 25, 2025
 · 
6 min read
Press Releases
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
June 25, 2025
 · 
5 min read
Press Releases
ONCare Alliance and Exigent Research Launch Groundbreaking Outpatient Bispecifics Program, Redefining Cancer Care Access, Support and Innovation
June 25, 2025
 · 
3 min read
Load More